Related Experiment Video

Updated: May 29, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Long-term myocardial recovery after mitral valve replacement in noncompaction cardiomyopathy

Tariq Bhat1, Thomas Costantino, Hilal Bhat

  • 1Department of Medicine, Staten Island University Hospital, New York, 475 Seaview Ave, Staten Island, New York 10305, USA. mohiuddin_bhat@yahoo.com

Journal of Cardiothoracic Surgery
|October 1, 2011
PubMed

Insights

Isolated noncompaction of the left ventricle, a rare heart condition, can cause severe mitral regurgitation. This case study shows successful mitral valve replacement in an elderly patient, leading to significant myocardial recovery.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Congenital Heart Disease

Background:

  • Isolated noncompaction of the left ventricle (ILVNC) is a rare congenital cardiomyopathy.
  • Literature on ILVNC is limited, primarily consisting of case reports and series.
  • Severe mitral regurgitation is an increasingly recognized complication of ILVNC.

Observation:

  • This report details a case of an elderly female patient diagnosed with ILVNC.
  • The patient presented with severe mitral regurgitation secondary to ILVNC.
  • Management options for this specific complication in elderly patients are not well-established.

Findings:

  • The patient underwent successful mitral valve replacement.
  • A follow-up of 1.5 years demonstrated significant recovery of left ventricular myocardial function.
  • This suggests mitral valve replacement is a viable treatment option for ILVNC with severe mitral regurgitation in select elderly patients.

Implications:

  • This case highlights the potential for significant myocardial recovery after intervention in elderly patients with ILVNC and severe mitral regurgitation.
  • It contributes to the limited evidence base regarding the management of this rare condition.
  • Further research into the long-term outcomes and optimal management strategies for ILVNC is warranted.

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...